These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1899229)

  • 21. Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.
    Roman C; Platero JS; Shuman J; Calame K
    Genes Dev; 1990 Aug; 4(8):1404-15. PubMed ID: 2121606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3' enhancer.
    Grant PA; Andersson T; Neurath MF; Arulampalam V; Bauch A; Müller R; Reth M; Pettersson S
    EMBO J; 1996 Dec; 15(23):6691-700. PubMed ID: 8978695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BZLF1 (ZEBRA, Zta) protein of Epstein-Barr virus selected in a yeast one-hybrid system by binding to a consensus site in the IgH intronic enhancer: a role in immunoglobulin expression?
    Gstaiger M; Hovens C; Georgiev O; Knoepfel L; Schaffner W
    Biol Chem; 1996 Oct; 377(10):669-73. PubMed ID: 8922596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
    Laurencikiene J; Deveikaite V; Severinson E
    J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Human immunoglobulin heavy-chain gene intronic enhancer segment HE2 (microB) functions as a major B-cell specific cis-element at cellular level as well as in transgenic mice].
    Enjoji M
    Fukuoka Igaku Zasshi; 1992 Jun; 83(6):262-74. PubMed ID: 1511952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
    Sun Z; Kitchingman GR
    Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells.
    Wasylyk C; Wasylyk B
    EMBO J; 1986 Mar; 5(3):553-60. PubMed ID: 3011412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer.
    German MS; Blanar MA; Nelson C; Moss LG; Rutter WJ
    Mol Endocrinol; 1991 Feb; 5(2):292-9. PubMed ID: 1710033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoid-specific transcriptional activation by components of the IgH enhancer: studies on the E2/E3 and octanucleotide elements.
    Cook GP; Neuberger MS
    Nucleic Acids Res; 1990 Jun; 18(12):3565-71. PubMed ID: 2114013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
    Voronova AF; Lee F
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer.
    Gerster T; Matthias P; Thali M; Jiricny J; Schaffner W
    EMBO J; 1987 May; 6(5):1323-30. PubMed ID: 3038516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pax5 (BSAP) regulates the murine immunoglobulin 3' alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription.
    Neurath MF; Max EE; Strober W
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5336-40. PubMed ID: 7777508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor.
    Lenardo MJ; Staudt L; Robbins P; Kuang A; Mulligan RC; Baltimore D
    Science; 1989 Jan; 243(4890):544-6. PubMed ID: 2536195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer.
    Imler JL; Lemaire C; Wasylyk C; Wasylyk B
    Mol Cell Biol; 1987 Jul; 7(7):2558-67. PubMed ID: 3039350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK; Judde JG; Max EE; Magrath IT
    J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG box-activating factors 1 and 2, two HMG box transcription factors that bind the human Ig heavy chain enhancer.
    Stevens S; Ordentlich P; Sen R; Kadesch T
    J Immunol; 1996 Oct; 157(8):3491-8. PubMed ID: 8871648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
    Singh M; Birshtein BK
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.
    Voronova A; Baltimore D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4722-6. PubMed ID: 2112746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell development arrest upon insertion of a neo gene between JH and Emu: promoter competition results in transcriptional silencing of germline JH and complete VDJ rearrangements.
    Delpy L; Decourt C; Le Bert M; Cogné M
    J Immunol; 2002 Dec; 169(12):6875-82. PubMed ID: 12471120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.